MYRIAD GENETICS INC (MYGN) Net Cash Provided by (Used in) Financing Activities USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Myriad Genetics Inc quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
  • Myriad Genetics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$8.8M, a 79.6% decline year-over-year.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$8.8M -$3.9M -79.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $153M +$161M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q1 2023 -$4.9M -$100K -2.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$8M +$143M +94.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q1 2022 -$4.8M +$43.7M +90.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$151M -$141M -1406% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q1 2021 -$48.5M -$48.7M -24350% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 -$3.9M +$8.4M +68.3% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$10M -$192M -105% Jul 1, 2019 Jun 30, 2020 10-K 2023-03-01
Q1 2020 $200K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q3 2019 -$12.3M -$264M -105% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $182M +$277M Jul 1, 2018 Jun 30, 2019 10-K 2022-02-25
Q3 2018 $252M +$275M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$95M -$167M -232% Jul 1, 2017 Jun 30, 2018 10-KT 2021-03-16
Q3 2017 -$23.3M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $71.8M +$140M Jul 1, 2016 Jun 30, 2017 10-K 2019-08-13
Q2 2016 -$68.3M Jul 1, 2015 Jun 30, 2016 10-K 2018-08-24
Q3 2013 -$102M -$64.4M -173% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q2 2013 -$80.6M -$11.3M -16.3% Jul 1, 2012 Jun 30, 2013 10-K 2013-08-14
Q3 2012 -$37.1M -$17.8M -92.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$69.2M +$47.4M +40.6% Jul 1, 2011 Jun 30, 2012 10-K 2013-08-14
Q3 2011 -$19.3M -$3.79M -24.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$117M -$67.5M -138% Jul 1, 2010 Jun 30, 2011 10-K 2013-08-14
Q3 2010 -$15.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q2 2010 -$49.1M Jul 1, 2009 Jun 30, 2010 10-K 2012-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.